Cambridge, England (ots/PRNewswire) - - Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene, further growing kits and assays portfolio - Supporting the growing demand of the sector and accelerating execution of strategic plan Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the ...
The International Osteoporosis Foundation (IOF)
Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...
Seibersdorf Labor GmbH; Isotopia Molecular Imaging
Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for ...
The Hague, Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a separate company as per January 2022 to directly access the capital markets. This will help to fund pipeline development to progress its highly ...
Heidelberg, Germany (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that it has implemented and applies a quality management system in accordance with Annex IX, Chapter I of the EU ...
Fresenius Kabi Deutschland GmbH
Bad Homburg, Germany (ots/PRNewswire) - Real-world-data on the medical nutrition practice in Intensive Care Units (ICU) for critically ill patients is limited so far. To close this knowledge gap, Fresenius Kabi started EuroPN Study in 2019 in eleven European countries with around 100 participating hospitals[1]. At ...
Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine), a leading European specialist pharmaceutical company, celebrates its 30th anniversary of continuous innovation in bowel preparations at the United European Gastroenterology (UEG) Week Virtual. Bowel preparations are used in colonoscopy to prevent and diagnose ...
Jerusalem (ots/PRNewswire) - Home-based Urinalysis technology innovator, Olive Diagnostics, begins financing round led by the Maccabi Foundation, eHealth Ventures and Venturing Ltd., as it readies for market launch Olive Diagnostics, developer of the world's first optical sensor for passive and seamless uranalysis ...
The Hague, The Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos announced it has secured another EUR32 million in funding to further develop its endolysin platform technology, based on targeted killing of only unwanted bacteria. This funding round will help Micreos accelerate its clinical ...
Geneva (ots/PRNewswire) - - Cardiovascular disease (CVD) remains world's biggest killer, claiming 18.6 million lives per year On World Heart Day, 29 September 2021, the World Heart Federation (WHF) is calling on the international community to bring digital cardiovascular health services to millions worldwide. COVID-19 has seen an explosion in telemedicine, with a 40%1 ...
Prague (ots/PRNewswire) - Partnership with Coursera boosts the offering after pilot in Summer Zentiva announces the launch of the Zentiva Academy, its new digital learning and development platform aimed at providing its employees with the best opportunities for their professional and personal growth. The program gathers a range of assets developed in-house by Zentiva-Talents and includes training by external partners as ...
Rehovot, Israel (ots/PRNewswire) - BASED OF THE SATISFACTORY SAFETY DATA OF VIDAC VDA 1102 ON SELECTED PATIENTS VIDAC PHARMA RECEIVED AUTHORIZATION TO WIDEN THE SCOPE OF THE TRIAL TO CTCL WHOLE SPECTRUM OF CONDITIONS. "WE ARE VERY SATISFIED WITH THE RESULTS OF THE FIRST STEP WHICH ON TOP OF THE SAFETY RESULTS GRANTED TO OUR TRIAL A DOSE RANGING PROTOCOL AUTHORIZATION. ...
Arnhem, Netherlands and Hangzhou, China (ots/PRNewswire) - Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine's medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle assist devices based on innovative pulsatile ...
New York (ots/PRNewswire) - Following a successful pilot with Bradford Teaching Hospitals, TytoCare to be utilised by 14 NHS organisations across Yorkshire and Humber in 26 projects to deliver high quality virtual care to patients TytoCare, the global health care industry's first all-in-one modular device and ...
Rehovot, Israel (ots/PRNewswire) - Vidac Pharma Ltd. announces that it was granted a USA Patent for a new chemical family of compounds targeting the HK2-VDAC system developed by the company. The new compounds are hydrophilic and were developed to fit systemic use such as IV, IM and/or Per-Os use. "This is opening the way to explore possible treatment of solid tumors overexpressing HK2 such as Prostate, Pancreas and other ...
Parma, Italy (ots/PRNewswire) - Produced by the Economist Intelligence Unit and commissioned by Chiesi Group, a new report Climate change and its impact on lung health: a focus on Europe says climate change is damaging respiratory health in ways not commonly known.i In Europe, climate change disproportionately affects the vulnerable, those with underlying health conditions and the economically disadvantagedi. The report ...
Paris (ots/PRNewswire) - Servier and Neurochlore announce that no sign of effectiveness was observed in their two phase 3 clinical studies assessing bumetanide versus placebo in the treatment of Autism Spectrum Disorders (ASD) in children and adolescents. As a consequence, Servier and Neurochlore have decided, by ...
Poda Lifestyle and Wellness Ltd.
Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC PINK: PODAF) is pleased to announce that Dr. Jagdeep Gupta, MD ("Dr. Gupta"), Chief Medical Officer of the Company, has commenced setting up the first clinical trials for Poda's smoking cessation products. Dr. Gupta commented, "I have already initiated the process of setting up the first clinical trials ...
Kfar Saba, Israel (ots/PRNewswire) - According to a Two-Year Randomized and Controlled Multinational IDE Study CartiHeal Ltd, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device Designation by the FDA last ...
Tel Aviv, Israel (ots/PRNewswire) - Radiaction Medical Ltd. ("Radication"), a medical device company, announced today that it was granted additional patents in the US and Japan, protecting key technological developments of its radiation shielding device. Radiaction, is revolutionizing radiation protection by providing full-body shielding to all medical personnel during ...
Amsterdam, Netherlands and Louisville, Ky. (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), a Kentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will register and commercialise ...
Cambridge (ots/PRNewswire) - Supporting accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforcing commitment to the region as Abcam approaches 20 years of US presence Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility is a central ...
Paris (ots/PRNewswire) - Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases. Under the collaboration ...
Nyon, Switzerland (ots/PRNewswire) - New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. Today sees the launch of Let's treat it right, a major new health education campaign designed to bridge a knowledge gap ...
Barcelona, Spain and Copenhagen, Denmark (ots/PRNewswire) - - The successful completion of a decentralized procedure is the final step before national marketing authorizations can be granted by the European countries - MC2 Therapeutics has granted Almirall exclusive European rights to commercialize this topical ...
Wuhan (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This short ...
Brussels and Castres, France (ots/PRNewswire) - Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients ...